EC Number   |
Substrates   |
Products   |
Reversibility   |
|---|
 3.2.1.125 | 1,2,19,20-tetrahydroraucaffricine + H2O |
87% of activity compared to raucaffricine |
17-O-acetylnorajmaline + D-glucose |
- |
? |
 3.2.1.125 | 1,2-(S)-dihydro-raucaffricine + H2O |
98% acivity compared to raucaffricine |
2beta(R)-1,2-dihydrovomilenine + D-glucose |
- |
? |
 3.2.1.125 | 1,2-dihydro-1-methylraucaffricine + H2O |
36% of activity compared to raucaffricine |
acetic acid 3-ethylidene-4-hydroxy-13-methyl-1,3,4,7,8,13,13a,13b-octahydro-2H,6H-2,7-cyclo-6,8a-methano-pyrido[1',2':1,2]azepino[3,4-b]indol-8-yl ester + D-glucose |
- |
? |
 3.2.1.125 | 1,2-dihydroraucaffricine + H2O |
98% of activity compared to raucaffricine |
2beta(R)-1,2-dihydrovomilenine + D-glucose |
- |
? |
 3.2.1.125 | 1,2-dihydroraucaffricine + H2O |
- |
2beta(R)-1,2-dihydrovomilenine + D-glucose |
- |
? |
 3.2.1.125 | 1,2-dihydroraucaffricine + H2O |
recombinant RG |
? |
- |
? |
 3.2.1.125 | 1-methyl-1,2-dihydroraucaffricine + H2O |
recombinant RG |
? |
- |
? |
 3.2.1.125 | 17-O-deacetyl-1,2-dihydroraucaffricine + H2O |
95% of activity compared to raucaffricine |
3-ethylidene-1,3,4,7,8,13,13a,13b-octahydro-2H,6H-2,7-cyclo-6,8a-methano-pyrido[1',2':1,2]azepino[3,4-b]indole-4,8-diol + D-glucose |
- |
? |
 3.2.1.125 | 21-glucopyranosyl-hydroxysarpagan-17-al + H2O |
recombinant RG |
? |
- |
? |
 3.2.1.125 | 21-glucopyranosyl-hydroxysarpagan-17-ol + H2O |
recombinant RG |
? |
- |
? |